# Study of AG-120 and AG-881 in Subjects With Low Grade Glioma

> **NCT03343197** · PHASE1 · COMPLETED · sponsor: **Institut de Recherches Internationales Servier** · enrollment: 49 (actual)

## Conditions studied

- Glioma

## Interventions

- **DRUG:** AG-120
- **DRUG:** AG881

## Key facts

- **NCT ID:** NCT03343197
- **Lead sponsor:** Institut de Recherches Internationales Servier
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-20
- **Primary completion:** 2019-08-02
- **Final completion:** 2025-03-28
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03343197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03343197, "Study of AG-120 and AG-881 in Subjects With Low Grade Glioma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03343197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*